In the specialized field of biochemical research, the CGKRK peptide has emerged as a subject of significant interest. As an enthusiast who follows advancements in peptide synthesis and delivery systems, I have spent considerable time reviewing the literature regarding its unique characteristics. This article aims to summarize my observations on this pentapeptide, focusing on its structural properties and its role in laboratory-based targeting studies.
Understanding the CG by AA Alobaid·2025·Cited by 2—The tumour homing peptide CGKRK binds to breast cancer cell lines. •. The placental homing peptides NKG and RSG also bind to breast cancer cells. •.Read more KRK Peptide Structure
The CGKRK peptide (Cys-Gly-Lys-Arg-Lys) is a short, five-amino-acid sequence that has garnered attention for its specific biochemical behavior. Unlike many other sequences, this peptide is characterized by its ability to facilitate cellular interactions. From a synthesis perspective, researchers often use the Fmoc s Cell-penetrating peptide CGKRK mediates efficient and olid-phase peptide synthesis strategy to synthesize the CGKRK pentapeptide. This method allows for high purity, which is critical when evaluating the ability of CGKRK to efficiently bind and penetrate the urothelium in experimental models.
When handling this compound, storage is a vital factor. It CGKRK-targeted lipid nanoparticles enhance in vivo is typically recommended to keep it in a lyophilized form at 0-5°C, as long-term storage might lead to the formation The Fmoc solid-phase peptide synthesis strategy (as shown schematically in Figure 1) was used tosynthesize the CGKRK pentapeptide. Briefly, 500 mg of H-Lys(Boc)- Read more of a dimerized product, which could alter its experimental profile.
Mechanisms and Targeting Capabilities
My interest in this molecule stems from its reputation as a tumor homing peptide. In various laboratory settings, it has been observed that CGKRK is one of the well-known tumor targeting peptides that displays a high affinity for angiogenic blood vessels and specific cell lines.
Key Observations:
* Cell Penetration: As a cell-penetrating peptide CGKRK functions by mediating internalization through energy-dependent pathways and interactions with heparin sulfate.
* Targeting Specificity: It has been documented that CGKRK peptides can specially bind to tumor cells and neovascular endothelial cells while largely sparing normal, healthy tissues. This specificity is a cornerstone of its utility in modern research.
* Diverse Applications: Beyond standard tumor research, recent studies have shown that it can selectively target placental tissues in humans an 2 days ago—Thispeptideacts as a bridge, holding a fluorophore and a quencher in close proximity. In healthy tissues, the fluorescence is suppressed.Read more d mice, making it a robust option for researchers investigating placental biological markers.
* Comparative Analysis: In some studies, researchers compare it to other known ligands like the cRGDyK peptide. While both target specific receptors, the unique sequence of the CGKRK peptide offers a distinct pathway for molecular interaction.
Integration into Advanced Delivery Systems
A major area where I have seen progress is in the development of CGKRK peptide-functionalized nanoparticulate DDS (drug delivery systems). By conjugating the peptide to the surface of lipid nanoparticles or na Similar to the CREKA peptide, the CGKRK peptidecan also specially bind to tumor cells and neovascular endothelial cellswith high affinity. Thus, it has Read more nogels, researchers aim to improve the precision of their experimental delivery models.
For instance, the tumour homing peptide CGKRK binds to breast cancer cell lines with notable efficacy in vitro. This high cellular internalization, contributed by th by Q Hu·2013·Cited by 101—Previous studies showed that intravenous injectedCGKRK peptidesspecifically recognized the vessels in most tumors but not those in normal tissues [28].Read more e transmembrane effect of the cellpenetrating peptide CGKRK, makes it a favorable candidate for researchers working on experimental delivery vehicles that require high site-specificity.
Final Reflections
The study of CGKRK continues to provide valuable insights into molecular recognition. Whether it is being explored for its ability to target tumor vasculature or its potential in mucosal targeting, the data consistently highlights its role as a versatile tool for laboratory investigations. As we continue to refine the synthesis and application of these molecules, the precision with which we can study cellular interfaces will likely improve, paving the way for more sophisticated biochemical assays.
***
*Disclaimer: This content is for in Similar to the CREKA peptide, the CGKRK peptidecan also specially bind to tumor cells and neovascular endothelial cellswith high affinity. Thus, it has Read more formational purposes for research enthusiasts only. It does not provide medical, clinical, or human-use advice. Always consult with institutional biosafety committees and adhere to laboratory protocols when working with biochemical agents.*